American Journal of Medical Genetics Part C-Seminars in Medical Geneti

Papers
(The median citation count of American Journal of Medical Genetics Part C-Seminars in Medical Geneti is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Bone health in RASopathies83
Correction to “The Rise of the Genetic Counseling Profession in China”80
Beyond chromosome analysis: Additional genetic testing practice in a Down syndrome clinic51
C3 glomerulopathy: Understanding an ultra‐rare complement‐mediated renal disease49
Newborn screening research sponsored by the NIH: From diagnostic paradigms to precision therapeutics45
Catatonia responsive to corticosteroids in a patient with an SCN2A variant37
Endocrinological manifestations in RASopathies37
Health care satisfaction and medical literacy habits among caregivers of individuals with Down syndrome36
Down syndrome across the lifespan30
Evolution of Health Care in Turner Syndrome26
Everyone Is a Tomato: Metagnostic Narratives of Genetic Revelation25
Proximal urea cycle defects are challenging to detect with newborn screening: Results of a prospective pilot study using post‐analytical tools24
Central nervous system involvement in individuals withRASopathies24
23
Table of Contents, Volume 196, Number 4, December 202422
A Genomic Analysis of Usher Syndrome: Population‐Scale Prevalence and Therapeutic Targets22
Review of Cutaneous Manifestations in Myhre Syndrome With Histopathological Analyses and Genotype–Phenotype Correlation22
Research Review of Myhre Syndrome19
Neurodevelopmental and other psychiatric disorders in 22q11.2 deletion syndrome from childhood to adult age: Prospective longitudinal study of 100 individuals19
18
Publication schedule for 202317
Retrospective review of the code status of individuals with Down syndrome during the COVID‐19 era16
My Journey With Arthrogryposis and Some of the People Who Made a Difference16
Co‐occurring conditions in Down syndrome: Findings from a clinical database15
14
Infantile epileptic spasms syndrome in children with cardiofaciocutanous syndrome: Clinical presentation and associations with genotype13
Genetic testing and glomerular hematuria—A nephrologist's perspective13
Newborn screening and the recommended uniform screening panel: Optimal submissions and suggested improvements based on an advocacy organization's decade‐long experience13
Revisiting the Neuropsychological and Clinical Profile of Mosaic Turner Syndrome With a Ring X Chromosome13
Unraveling the Mechanistic Spectrum of Myhre Syndrome: SMAD4 Signaling Disruption, Skeletal Phenotypes, and Translational Innovation13
Children with Down syndrome who experience developmental skill loss, characterization, and phenomenology: A case series12
Caregivers' concerns and supports needed to care for adults with Down syndrome12
Family Lore, a Variant of Uncertain Significance, and CADASIL10
Adult experiences in Beckwith–Wiedemann syndrome10
Correction to “Experiences With Offering Pro Bono Medical Genetics Services in the West Indies: Benefits to Patients, Physicians, and the Community”9
Normal joint range of motion in children with Down syndrome9
Non‐Invasive Prenatal Testing by Cell‐Free DNA ( cfNIPT ) for Detecting Turner Syndrome With Mosai9
Occurrence of mosaic Down syndrome and prevalence of co‐occurring conditions in Medicaid enrolled adults, 2016–20199
Table of Contents, Volume 199, Number 1, March 20259
Cover Image, Volume 196, Number 1, March 20249
Duchenne expert physician perspectives on Duchenne newborn screening and early Duchenne care9
A plot TWIST9
In Utero Therapies, the Next Frontier8
Table of Contents, Volume 190, Number 2, June 20228
Disease mechanisms of monogenic congenital anomalies of the kidney and urinary tract8
Whole‐genome sequencing holds the key to the success of gene‐targeted therapies8
Autism and mild epilepsy associated with a de novo missense pathogenic variant in the GTPase effector domain of DNM18
Table of Contents, Volume 193, Number 4, December 20237
Cover Image, Volume 190, Number 3, September 20227
Parental Decision‐Making Following a Prenatal Diagnosis of Turner Syndrome: A Systematic Review7
Monogenic focal segmental glomerulosclerosis: A conceptual framework for identification and management of a heterogeneous disease7
Integration of EpiSign, facial phenotyping, and likelihood ratio interpretation of clinical abnormalities in the re‐classification of an ARID1B missense variant7
Ophthalmologic and neuro‐ophthalmologic findings in children with Down syndrome7
Cover Image, Volume 193, Number 1, March 20236
Genesis and genetics of a miracle6
Repurposing With Purpose: Treatment of Bachmann–Bupp Syndrome With Eflornithine and Implications for Other Polyaminopathies6
New prospectives on treatment opportunities in RASopathies6
Data sharing to advance gene‐targeted therapies in rare diseases6
Circles6
Ode to Fiona: The Face of Fortitude in FBXL4 Deficiency6
Artificial intelligence and the impact on medical genetics5
Treatment of PDGFRB ‐Related Penttinen Syndrome With Imatinib in a Young Child5
5
Autosomal dominant tubulointerstitial kidney disease: A review5
Table of Contents, Volume 193, Number 1, March 20235
The Diagnosis That Arrived Decades Late: Living Without and Then With Myhre Syndrome5
The National Institutes of Health INvestigation of Co‐occurring conditions across the Lifespan to Understand Down syndromE (INCLU5
Comment From the Guest Editors4
Cover Image, Volume 199, Number 1, March 20254
Table of Contents, Volume 199, Number 3, September 20254
COL1A1 and COL1A2 variants in Ehlers‐Danlos syndrome phenotypes and COL1‐related overlap disorder4
Table of Contents, Volume 193, Number 3, September 20234
4
Investigations of an individual with a Marfanoid habitus, mild intellectual disability, and severe social anxiety identifies PCDHGA5 as a candidate neuro3
Comments From the Guest Editors3
Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy3
Pneumonia vaccine response in individuals with Down syndrome at three specialty clinics3
Introduction to special issue for kidney genetics3
Systematic assessment of monogenic etiology in adult‐onset kidney stone formers undergoing urological intervention–evidence for genetic pretest probability3
Prenatal Evaluation of RNU4‐2 Variants in Fetuses With Central Nervous System Anomalies3
The heart in RASopathies3
Newborn screening for neurodevelopmental diseases: Are we there yet?3
Natural history of MRAS‐related Noonan syndrome: Evidence of mild adult‐onset left ventricular hypertrophy and neuropsychiatric features3
Publication schedule for 20233
Invisible strings3
Cover Image, Volume 190, Number 2, June 20223
3
Development of webcam‐collected and artificial‐intelligence‐derived social and cognitive performance measures for neurodevelopmental genetic syndromes3
Cover Image, Volume 193, Number 3, September 20233
Clinical overview on RASopathies2
First a Provider, Now a Patient: Receiving a Devastating Diagnosis Through the Patient Portal2
Family adaptation in families of individuals with Down syndrome from 12 countries2
Why must the debate continue on Krabbe disease newborn screening?2
Multiorgan manifestations of COL4A1 and COL4A2<2
Molecular advances, clinical management, and treatment opportunities in RASopathies2
Milestone Attainment in Young Children With Arthrogryposis Multiplex Congenita: Developmental Profile and Associated Factors2
Spectrum of white matter abnormalities associated with FOXC1‐related disorders in two unrelated cases2
A review of economic issues for gene‐targeted therapies: Value, affordability, and access2
Applications of artificial intelligence in clinical laboratory genomics2
Application of facial analysis Technology in Clinical Genetics: Considerations for diverse populations2
On stillness2
Spreading the Word: Communicating Evidence‐Based Guidelines About Turner Syndrome to Patients, Parents, Providers, and Payors2
Healthy transition: Roadmap for young adults with Down syndrome to adulthood2
Publication schedule for 20232
Therapy for Myhre Syndrome: Goals, Misconceptions, and Current Agents1
Cover Image, Volume 199, Number 3, September 20251
Quality of life measures in children with Down syndrome with disorders of gut–brain interaction1
DNAJC21‐related thrombocytopenia in a young adult female1
The Pediatric Integrated Care Survey (PICS) in a multidisciplinary clinic for Down syndrome1
1
Growth and Growth‐Promoting Treatments in Turner Syndrome1
Perspectives and Insights Into Phenylketonuria: Patient Narratives About the Early Years Following Newborn Screening1
Different, Not Less1
Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies1
A Rorschach Test1
1
Note from the editors1
1
Mental health in adults living with arthrogryposis multiplex congenita1
Publication schedule for 20221
Turner Syndrome and Psychosocial Interventions: Recommendations for Collaborative Communication Between Medical and School Teams1
Gene‐targeted therapies: Overview and implications1
Practicalities (and real‐life experiences) of dementia in adults with Down syndrome1
Evaluation of the Mid and Lower Face in Three Females With Myhre Syndrome: Objective Methods to Supplement Subjective Assessment1
Special issue: Newborn screening research1
Psychopharmacological treatments in Down syndrome and autism spectrum disorder: State of the research and practical considerations1
Parent Narratives Provide Perspectives on the Experience of Care in Trisomy 181
Diagnostic experiences of Duchenne families and their preferences for newborn screening: A mixed‐methods study1
0.15166020393372